Regency Centers Corporation
Regency Centers Corporation (REG) Financial Performance & Income Statement Overview
Explore the financials of Regency Centers Corporation (REG), including yearly and quarterly data on income, cash flow, and balance sheets.
Regency Centers Corporation (REG) Income Statement & Financial Overview
Review Regency Centers Corporation REG income statement with detailed quarterly and annual figures.
Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $380.76M | $372.54M | $360.07M | $359.11M |
Cost of Revenue | $210.67M | $114.30M | $206.63M | $205.94M |
Gross Profit | $170.09M | $258.24M | $153.45M | $153.17M |
Gross Profit Ratio | $0.45 | $0.69 | $0.43 | $0.43 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $24.42M | $26.02M | $25.07M | $24.24M |
Operating Expenses | $24.42M | $122.73M | $254.06M | $128.27M |
Total Costs & Expenses | $68.46M | $237.03M | $236.23M | $234.40M |
Interest Income | $1.34M | $1.40M | $1.59M | $4.02M |
Interest Expense | $0.00 | $48.22M | $48.37M | $47.05M |
Depreciation & Amortization | $96.77M | $89.89M | $100.95M | $100.97M |
EBITDA | $242.44M | $229.07M | $225.33M | $385.44M |
EBITDA Ratio | $0.64 | $0.61 | $0.63 | $1.07 |
Operating Income | $145.67M | $135.51M | $124.38M | $124.71M |
Operating Income Ratio | $0.38 | $0.36 | $0.35 | $0.35 |
Other Income/Expenses (Net) | -$33.95M | -$46.83M | -$20.80M | -$19.78M |
Income Before Tax | $111.72M | $88.68M | $103.58M | $104.93M |
Income Before Tax Ratio | $0.29 | $0.24 | $0.29 | $0.29 |
Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Net Income | $109.59M | $86.48M | $101.47M | $102.67M |
Net Income Ratio | $0.29 | $0.23 | $0.28 | $0.29 |
EPS | $0.60 | $0.46 | $0.54 | $0.54 |
Diluted EPS | $0.58 | $0.46 | $0.54 | $0.54 |
Weighted Avg Shares Outstanding | $181.81M | $180.88M | $182.87M | $183.70M |
Weighted Avg Shares Outstanding (Diluted) | $181.81M | $181.80M | $182.87M | $183.87M |
Over the past four quarters, Regency Centers Corporation demonstrated steady revenue growth, increasing from $359.11M in Q2 2024 to $380.76M in Q1 2025. Operating income reached $145.67M in Q1 2025, maintaining a consistent 38% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $242.44M, reflecting operational efficiency. Net income rose to $109.59M, with EPS at $0.60. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan